期刊文献+

不同治疗方式对结核性胸腔积液预后的影响效果分析

不同治疗方式对结核性胸腔积液预后的影响效果分析
下载PDF
导出
摘要 目的:探讨结核性渗出性胸腔积液治疗方式。方法:以106例中等量以上积液的结核性胸膜炎病人为研究对象。患者按入院先后顺序随机分为三组。A组36例,胸腔置管引流并胸腔内注射微卡(母牛分枝杆菌菌苗);B组39例,单纯置管引流;C组31例,常规胸腔穿刺抽液每周1~2次。三组患者的化疗方案均为2HRZE(S)/4HR。C组口服强的松30mg/日。治疗1个月评价疗效。结果:1个月A组胸液控制率95.3%,显效31例(86.1%),有效3例(8.3%),无效2例(5.6%),6个月总有效率100%;B组胸液控制率91.1%,显效32例(82%),有效4例(10.3%),无效3例(7.7%),6个月总有效率100%;C组胸液控制率66.6%,显效2例(6.5%),有效18例(58.1%),无效11例(35.4%),6个月总有效率83.3%。结论:深静脉导管引流胸腔积液,注药与不注药差异无显著性,但明显优于常规胸穿抽液。 Objective:To investigate the offect of tuberculous exudative pleural effusion treatment. Methods: 106 patients with moderate or more effusion of tuberculous pleurisy. In patients were randomly divided into 3 groups. A group included 36 patients, chest tube drainage and intrapleural injection of micro - card ( Mycobacterium vaccae vaccine) ; B group included 39 cases, simple tube drainage; C group included 31 eases, routine thoracic fluid puncture 1 to 2 times per week . 3 groups of patients with chemotherapy were 2HRZE ( S)/4HR. Cheek one month treatment. Results:month A group of pleural effusion control rate was 95.3% ,effective in 31 cases (86.1%) ,effective in 3 cases (8. 3%), 2 cases (5. 6%), 6 months, the total effective rate 100%; B group of pleural effusion control rate of 91.1% were cured,32 cases (82%) ,effective in 4 cases (10.3%) and 3 cases (7.7%) ,6 months,the total effective rate 100% ;C group pleural effusion control rate was 66.6% were cured,2 cases (6. 5% ) , effective in 18 cases (58.1% ), ineffective in 11 cases (35.4%) ,6 months,total effective rate was 83.3%. Conclusion: while deep venous catheter drainage of pleural effusion, between injection and noninjection there was no significant difference, but obviously superior to conventional chest wearing a pumping fluid.
作者 丁荣梅
出处 《中国社区医师(医学专业)》 2010年第16期40-41,共2页
关键词 结核 胸膜 胸腔积液 引流术 Tuberculosis pleural pleural effusion drainage.
  • 相关文献

参考文献6

二级参考文献19

  • 1何桥,谢灿茂,谭守勇,张克迅,邓晓华,竺澎波,易小平,张院良,蔡杏珊,黄丽晶,刘燕.大鼠结核性胸膜炎模型和胸腔炎症免疫反应的研究[J].中华结核和呼吸杂志,2005,28(2):117-121. 被引量:23
  • 2李为民,林震勋.胸液中γ干扰素的测定及诱生能力的观察[J].中华结核和呼吸杂志,1995,18(2):94-96. 被引量:19
  • 3[1]Chapman SJ,Davies RJ.The management of pleural space infections[J].Respirology,2004,9:4-11
  • 4[2]Talib SH,Verma GR,Arshad M,et al.Utility of intrapleural streptokinase in management of chronic empyemas[J].J Assoc Physicians India,2003,51:464-468
  • 5[5]Tillett W,Sherry S.The effect in patients with streptococcal fibrinolysis (streptokinase) and streptococcal desoxyribonuclease on fibrinous,purulent,and sanguinous pleural exudations[J].J Clin Invest,1949,28:173-190
  • 6[6]Hua CC,Chang LC,Chen YC,et al.Proinflammatory cytokines and fibrinolytic enzymes in tuberculous and malignant pleural effusions[J].Chest,1999,116:1292-1296
  • 7[7]Kwak SM,Park CS,Cho JH,et al.The effects of urokinase instillation therapy via percutaneous transthoracic catheter in loculated tuberculous pleural effusion:a randomized prospective study[J].Yonsei Med J,2004,45:822 -828
  • 8[8]Barnes NP,Hull J,Thomson AH.Medical management of parapneumonic pleural disease[J].Pediatr Pulmonol,2005,39:127-134
  • 9[9]Cochran JB,Tecklenburg FW,Turner RB,et al.Intrapleural instillation of fibrinolytic agents for treatment of pleural empyema[J].Pediatr Crit Care Med,2003,4:39-43
  • 10[10]Diacon AH,Theron J,Schuurmans MM,et al.Intrapleural streptokinase for empyema and complicated parapneumonic effusions[J].Am J Respir Crit Care Med,2004,170:49-53

共引文献82

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部